| Literature DB >> 15125940 |
Stefan Peukert1, Joachim Brendel, Bernard Pirard, Carsten Strübing, Heinz-Werner Kleemann, Thomas Böhme, Horst Hemmerle.
Abstract
The search for novel, potent Kv1.5 blockers based on an anthranilic amide scaffold employing a pharmacophore-based virtual screening approach is described. The synthesis and structure-activity relationships (SAR) with respect to inhibition of the Kv1.5 channel are discussed. The most potent compounds display sub-micromolar inhibition of Kv1.5 and no significant effect on the HERG channel. In addition, good oral bioavailability is demonstrated for compound 3i in rats.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15125940 DOI: 10.1016/j.bmcl.2004.03.057
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823